216 related articles for article (PubMed ID: 20832663)
21. A phase I trial of etanidazole and hyperfractionated radiotherapy in children with diffuse brainstem glioma.
Marcus KJ; Dutton SC; Barnes P; Coleman CN; Pomeroy SL; Goumnerova L; Billett AL; Kieran M; Tarbell NJ
Int J Radiat Oncol Biol Phys; 2003 Apr; 55(5):1182-5. PubMed ID: 12654425
[TBL] [Abstract][Full Text] [Related]
22. Clinical science and patient care: lessons from cooperative randomized clinical trials.
Cox JD
Int J Radiat Oncol Biol Phys; 1997 Sep; 39(2):273-4. PubMed ID: 9308927
[No Abstract] [Full Text] [Related]
23. Clinical trials of radiosensitizers: what should we expect?
Brown JM
Int J Radiat Oncol Biol Phys; 1984 Mar; 10(3):425-9. PubMed ID: 6231272
[TBL] [Abstract][Full Text] [Related]
24. Results of a phase II trial of external beam radiation with etanidazole (SR 2508) for the treatment of locally advanced prostate cancer (RTOG Protocol 90-20).
Lawton CA; Coleman CN; Buzydlowski JW; Forman JD; Marcial VA; DelRowe JD; Rotman M
Int J Radiat Oncol Biol Phys; 1996 Oct; 36(3):673-80. PubMed ID: 8948352
[TBL] [Abstract][Full Text] [Related]
25. Stereotactic ablative radiation therapy versus conventionally fractionated radiation therapy for stage I small cell lung cancer.
Verma V; Hasan S; Wegner RE; Abel S; Colonias A
Radiother Oncol; 2019 Feb; 131():145-149. PubMed ID: 30773182
[TBL] [Abstract][Full Text] [Related]
26. Stereotactic Ablative Radiation Therapy for the Treatment of Early-stage Non-Small-Cell Lung Cancer: CEPO Review and Recommendations.
Boily G; Filion É; Rakovich G; Kopek N; Tremblay L; Samson B; Goulet S; Roy I;
J Thorac Oncol; 2015 Jun; 10(6):872-82. PubMed ID: 26001140
[TBL] [Abstract][Full Text] [Related]
27. Therapeutic advantage of hypoxic cells in tumors: a theoretical study.
Brown JM; Koong A
J Natl Cancer Inst; 1991 Feb; 83(3):178-85. PubMed ID: 1988703
[TBL] [Abstract][Full Text] [Related]
28. The end of the hypoxic EPOch.
Aguilera TA; Giaccia AJ
Int J Radiat Oncol Biol Phys; 2015 Apr; 91(5):895-7. PubMed ID: 25832683
[No Abstract] [Full Text] [Related]
29. Stereotactic ablative radiotherapy versus standard radiotherapy in stage 1 non-small-cell lung cancer (TROG 09.02 CHISEL): a phase 3, open-label, randomised controlled trial.
Ball D; Mai GT; Vinod S; Babington S; Ruben J; Kron T; Chesson B; Herschtal A; Vanevski M; Rezo A; Elder C; Skala M; Wirth A; Wheeler G; Lim A; Shaw M; Schofield P; Irving L; Solomon B;
Lancet Oncol; 2019 Apr; 20(4):494-503. PubMed ID: 30770291
[TBL] [Abstract][Full Text] [Related]
30. In vivo radiosensitization efficacy of KU-2285 and etanidazole at clinically relevant low radiation doses.
Oya N; Shibamoto Y; Sasai K; Sugiyama T; Abe M
Int J Radiat Oncol Biol Phys; 1993 Dec; 27(5):1113-9. PubMed ID: 8262836
[TBL] [Abstract][Full Text] [Related]
31. Keynote address: hypoxic cell radiosensitizers: where next?
Brown JM
Int J Radiat Oncol Biol Phys; 1989 Apr; 16(4):987-93. PubMed ID: 2649468
[TBL] [Abstract][Full Text] [Related]
32. Dose escalation of the hypoxic cell sensitizer etanidazole combined with ifosfamide, carboplatin, etoposide, and autologous hematopoietic stem cell support.
Elias AD; Wheeler C; Ayash LJ; Schwartz G; Ibrahim J; Mills L; McCauley M; Coleman N; Warren D; Schnipper L; Antman KH; Teicher BA; Frei E
Clin Cancer Res; 1998 Jun; 4(6):1443-9. PubMed ID: 9626461
[TBL] [Abstract][Full Text] [Related]
33. Use of Stereotactic Ablative Radiotherapy (SABR) in Non-Small Cell Lung Cancer Measuring More Than 5 cm.
Tekatli H; van 't Hof S; Nossent EJ; Dahele M; Verbakel WFAR; Slotman BJ; Senan S
J Thorac Oncol; 2017 Jun; 12(6):974-982. PubMed ID: 28286243
[TBL] [Abstract][Full Text] [Related]
34. Stereotactic ablative radiation therapy for subcentimeter lung tumors: clinical, dosimetric, and image guidance considerations.
Louie AV; Senan S; Dahele M; Slotman BJ; Verbakel WF
Int J Radiat Oncol Biol Phys; 2014 Nov; 90(4):843-9. PubMed ID: 25585783
[TBL] [Abstract][Full Text] [Related]
35. Radiosensitization efficacy of KU-2285, RP-170 and etanidazole at low radiation doses: assessment by in vitro cytokinesis-block micronucleus assay.
Shibamoto Y; Streffer C; Sasai K; Oya N; Abe M
Int J Radiat Biol; 1992 Apr; 61(4):473-8. PubMed ID: 1349329
[TBL] [Abstract][Full Text] [Related]
36. Modification of alkylating agent induced cell kill by 2-nitroimidazoles in unclamped and clamped SC 9L tumors.
Wallen CA; Moore SK; Wheeler KT
Int J Radiat Oncol Biol Phys; 1992; 22(4):727-30. PubMed ID: 1531976
[TBL] [Abstract][Full Text] [Related]
37. Technique, pharmacokinetics, toxicity, and efficacy of intratumoral etanidazole and radiotherapy for treatment of spontaneous feline oral squamous cell carcinoma.
Evans SM; LaCreta F; Helfand S; VanWinkle T; Curran WJ; Brown DQ; Hanks G
Int J Radiat Oncol Biol Phys; 1991 Apr; 20(4):703-8. PubMed ID: 1825993
[TBL] [Abstract][Full Text] [Related]
38. Lung volume reduction after stereotactic ablative radiation therapy of lung tumors: potential application to emphysema.
Binkley MS; Shrager JB; Leung AN; Popat R; Trakul N; Atwood TF; Chaudhuri A; Maxim PG; Diehn M; Loo BW
Int J Radiat Oncol Biol Phys; 2014 Sep; 90(1):216-23. PubMed ID: 25015205
[TBL] [Abstract][Full Text] [Related]
39. Combined cytokinesis-block micronucleus and chromosomal aberration assay for the evaluation of radiosensitizers at low radiation doses.
Oya N; Shibamoto Y; Shibata T; Sasai K; Sugiyama T; Abe M
Int J Radiat Oncol Biol Phys; 1994 Dec; 30(5):1153-9. PubMed ID: 7961025
[TBL] [Abstract][Full Text] [Related]
40. Stereotactic ablative body radiotherapy for lung cancer.
Franks KN; Jain P; Snee MP
Clin Oncol (R Coll Radiol); 2015 May; 27(5):280-9. PubMed ID: 25746732
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]